Evaluation and Treatment of Sickle Cell Pain in the Emergency Department: Paths to a Better Future

Clinical Pediatric Emergency Medicine

Volumn 11, Issue 4, 2010, Pages 265-273

  Zempsky, William T ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

opioids; pain; sickle cell disease; vasoocclusive episode

Indexed keywords

EID: 84864821426     PISSN: 15228401     EISSN: 15582310     Source Type: Journal    
DOI: 10.1016/j.cpem.2010.09.002     Document Type: Article

References (56)

1. Ballas, S.K., Pain management of sickle cell disease. Hematol Oncol Clin North Am 19 (2005), 785–802.
2. Platt, O.S., Thorington, B.D., Brambilla, D.J., et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325 (1991), 11–16.
3. Yusuf, H.R., Atrah, H.K., Grosse, S.D., et al. Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007. Am J Prev Med 38 (2010), S536–541.
4. Yang, Y., Shah, A., Watson, M., et al. Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Pub Health Rep 110 (1997), 80–86.
5. Ballas, S.K., Sickle cell pain. 1998, IASP Press, Seattle (Wash).
6. Schechter, N.L., The management of pain in sickle cell disease. McGrath, P.J., Finley, G.A., (eds.) Chronic and recurrent pain in children and adolescents, 1999, IASP Press, Seattle (Wash), 99–114.
7. Dampier, C.D., Shapiro, B.S., Management of pain in sickle cell disease. Schechter, N.L., Berde, C.B., Yaster, M., (eds.), 2nd ed Pain in infants, children, and adolescents, 2003, Lippincott Williams & Wilkins, Philadelphia (Pa), 489–516.
8. Conner-Warren, R.L., Pain intensity and home pain management of children with sickle cell disease. Issues Compr Pediatr Nurs 19 (1996), 183–195.
9. Walco, G.A., Dampier, C.D., Pain in children and adolescents with sickle cell disease: a descriptive study. J Pediatr Psychol 15 (1990), 643–658.
10. Varni, J.W., Walco, C.A., Chronic and recurrent pain associated with pediatric chronic diseases. Issues Compr Pediatr Nurs 11 (1988), 73–86.
11. Smith, L.A., Oyeku, S.O., Homer, C., et al. Sickle cell disease: a question of equity and quality. Pediatrics 117 (2006), 1763–1770.
12. Todd, K.H., Green, C., Bonham, V.L., et al. Sickle cell disease related pain: crisis and conflict. J Pain 7 (2006), 453–458.
13. Brousseau, D.C., Owens, P.L., Mosso, A.L., et al. Acute care utilizations and rehospitalizations for sickle cell disease. JAMA 303 (2010), 1288–1294.
14. Boulet, S.L., Yanni, E.A., Creary, M.S., et al. Health status and healthcare use in a national sample of children with sickle cell disease. Am J Prev Med 38 (2010), S528–S535.
15. Eton, W.A., Hofrichter, J., Sickle cell hemoglobin polymerization. Adv Protein Chem 40 (1990), 63–279.
16. Embury, S.H., The not so simple process of sickle cell vasoocclusion. Microcirculation 11 (2004), 101–113.
17. Vekilov, P.G., Sickle-Cell haemoglobin polymerization: is it the primary pathogenic event of sickle cell anaemia?. Br J Haemotol 139 (2007), 173–184.
18. Beyer, J.E., Simmons, L.E., Woods, G.M., et al. A chronology of pain and comfort in children with sickle cell disease. Arch Pediatr Adolesc Med 153 (1999), 913–920.
19. Brandow, A.M., Brousseau, D., Pajewski, N.M., et al. Vaso-occlusive events in sickle cell disease: impact on child well-being. Pediatr Blood Cancer 54 (2009), 92–97.
20. Zempsky, W.T., Corsi, J.M., Loiselle, K.A., et al. Functional assessment for children hospitalized for sickle cell pain: a new paradigm. Blood, 2561, 2009, 114.
21. Pack-Mabien, A., Labbé, E., Herbert, D., et al. Nurses’ attitudes and practices in sickle cell pain management. Appl Nurs Res 14 (2001), 187–192.
22. Labbé, E., Physicians' attitude and practices in sickle cell disease pain management. J Palliat Care 21 (2005), 246–251.
23. Shapiro, B.S., Benjamin, L.J., Payne, R., et al. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage 14 (1997), 168–174.
24. Alleyne, J., Thomas, V.J., The management of sickle cell crisis pain as experienced by patients and their carers. J Adv Nurs 19 (1993), 725–732.
25. Harris, A., Parker, N., Barker, C., Adults with sickle cell disease: psychological impact and experience of hospital services. Psychol Health Med 3 (1998), 171–179.
26. Maxwell, K., Streetly, A., Bevan, D., Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. BMJ 318 (1999), 1585–1590.
27. McGrath, P.J., Turk, D.C., Dworkin, R.H., et al. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. Pain 9 (2008), 771–783.
28. Finley, G.A., McGrath, P.J., (eds.) Measurement of pain in infants and children, 1998, IASP Press, Seattle (Wash).
29. Platt, A., Eckman, J.R., Beasley, J., et al. Treating sickle cell pain: an update from the Georgia Comprehensive Sickle Cell Center. J Emerg Nurs 28 (2002), 297–303.
30. Rees, D.C., Olujohungbe, A.D., Parker, N.E., Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 120 (2003), 744–752.
31. Benjamin, L.J., Dampier, C.D., Jacox, A.K., et al. Guideline for the management of acute and chronic pain in sickle cell disease, 1999, American Pain Society, Glenview (Ill).
32. Johnston, C.C., Psychometric issues in the measurement of pain. Finley, G.A., McGrath, P.J., (eds.) Measurement of pain in infants and children, 1998, IASP Press, Seattle (Wash), 5–20.
33. Stinson, J.N., Kavanagh, T., Yamada, J., et al. Systematic review of the psychometric properties interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents. Pain 125 (2006), 143–157.
34. von Baeyer, C.L., Spagrud, L.J., McCormick, J.C., et al. Three new datasets supporting use of the numerical rating scale NRS-11) for children's self-reports of pain intensity. Pain 143 (2009), 223–227.
35. Woolf, C.J., Thompson, S.W., The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartate acid receptor activation: implication for the treatment of post-injury pain hypersensitivity states. Pain 44 (1991), 293–299.
36. Gil, K.M., Thompson, R.J., Keith, B.R., et al. Sickle cell disease pain in children and adolescents: change in pain frequency and coping strategies over time. J Pediatr Psychol 18 (1993), 621–637.
37. McCrae, J.D., Lumley, M.A., Health status in sickle cell disease: examining the roles of pain coping strategies, somatic awareness, and negative affectivity. J Behav Med 21 (1998), 35–55.
38. Varni, J.W., Rapoff, M.A., Waldron, S.A., et al. Chronic pain and emotional distress in children and adolescents. J Dev Behav Pediatr 17 (1996), 154–161.
39. Varni, J.W., Rapoff, M.A., Waldron, S.A., et al. Effects of perceived stress on pediatric chronic pain. J Behav Med 19 (1996), 515–528.
40. Palermo, T.M., Impact of recurrent and chronic pain on child and family daily functioning: a critical review of the literature. J Dev Behav Pediatr 21 (2000), 58–69.
41. Jacob, E., Miaskowski, C., Savedra, M., et al. Management of vaso-occlusive pain in children with sickle cell disease. J Pediatr Hematol Oncol 25 (2003), 307–311.
42. Zempsky, W.T., Loiselle, K.A., McKay, K., et al. Retrospective evaluation of pain assessment and treatment for vasoocclusive episodes in children with sickle cell disease. Pediatr Blood Cancer 51 (2008), 265–268.
43. Jacob, E., Miaskowski, C., Savedra, M., et al. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease. Pain 102 (2003), 187–193.
44. Bartolucci, P., El Murr, E., Roudot-Thoroval, F., et al. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. Blood 114 (2009), 3742–3747.
45. Hardwick, W.E., Givens, T.G., Monroe, K.W., et al. Effect of ketorolac in pediatric sickle cell vaso-oclusive pain crisis. Pediatr Emerg Care 15 (1999), 179–182.
46. Bieter, J.L., Simon, H.K., Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness. Arch Pedatri Adol Med 155 (2001), 496–500.
47. Darbari, D.S., Neely, M., VandenAnker, J., et al. Morphine pharmacokinetics in sickle cell disease: implications for pain management. Blood, 114, 2009, 2574.
48. Zempsky, W.T., Treatment of sickle cell pain: fostering trust and justice. JAMA 302 (2009), 2479–2480.
49. Elander, J., Lusher, J., Bevan, D., et al. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudo-addiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage 27 (2004), 156–169.
50. Thomas, V., Cognitive behavioral therapy in pain management for sickle cell disease. Int J Palliat Nurs 6 (2000), 434–442.
51. Broome, M.E., Maikler, V., Kelber, S., et al. An intervention to increase coping and reduce health care utilization for school-age children and adolescents with sickle cell disease. J Natl Black Nurses Assoc 12 (2001), 6–14.
52. Chen, E., Cole, S.W., Kato, P.M., A review of empirically supported psychosocial interventions for pain and adherence outcomes in sickle cell disease. J Pediatr Psychol 29 (2004), 197–209.
53. Lemanek, K.L., Ranalli, M., Lukens, C., A randomized controlled trial of massage therapy in children with sickle cell disease. J Pediatr Psychol 34 (2009), 1091–1096.
54. Sebigna, E.M., Shindell, D.L., Casella, J.F., et al. Pediatric patients with sickle cell disease: use of complementary and alternative therapies. J Altern Complement Med 12 (2006), 291–298.
55. Morrisey, L.K., Shea, J.O., Kalish, L.A., et al. Clinical practice guidelines improve the treatment of sickle cell vasoocclusive pain. Pediatr Blood Cancer 52 (2009), 369–372.
56. Givens, M., Rutherford, C., Joshi, G., et al. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease. J Emerg Med 32 (2007), 239–243.